Shirli R. Wall

Shirli R. Wall serves as a procurement specialist responsible for managing acquisitions within the medical laboratory services sector, ensuring compliance with federal contracting regulations and aligning purchases with public health objectives. Her role centers on the planning, solicitation, and award of contracts for clinical testing, diagnostic services, and laboratory infrastructure support, directly contributing to the agency’s mission of delivering accurate, timely, and scalable laboratory capabilities. She handles a range of acquisition types, including indefinite-delivery/indefinite-quantity (IDIQ) contracts, blanket purchase agreements (BPAs), and competitive sealed bids, with a focus on technical requirements tied to CLIA compliance, specimen handling protocols, and data interoperability standards. Wall’s contracting patterns reflect a consistent reliance on non-set-aside procurements, with 100% of her awards issued under full and open competition. This approach underscores a preference for market-driven selection based on technical merit, past performance, and cost-effectiveness, rather than socioeconomic set-asides. While no specific contractor relationships are identified in current data, her portfolio likely engages established medical diagnostics providers, reference laboratories, and specialized service vendors capable of meeting stringent regulatory and quality assurance benchmarks. Her procurement strategy demonstrates no utilization of 8(a), HUBZone, SDVOSB, or other socioeconomic set-asides, indicating a singular focus on capability-driven sourcing rather than socioeconomic targeting. This pattern suggests a prioritization of operational efficiency and technical fidelity in high-volume, high-accuracy laboratory environments. Wall’s expertise is narrowly concentrated in NAICS 621511—Medical Laboratories—reflecting deep specialization in clinical diagnostics, pathology services, molecular testing, and laboratory automation systems. She procures services including blood and tissue analysis, infectious disease screening, genetic testing, and laboratory information system (LIS) integration, demonstrating technical fluency in regulatory frameworks such as CLIA, CAP, and ISO 15189 standards. Her work supports mission-critical public health functions requiring precision, scalability, and compliance.